Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study

被引:31
作者
Kakino, Ryo [1 ,2 ,3 ]
Nakamura, Mitsuhiro [1 ,2 ]
Mitsuyoshi, Takamasa [2 ,4 ]
Shintani, Takashi [2 ,5 ]
Kokubo, Masaki [4 ]
Negoro, Yoshiharu [6 ]
Fushiki, Masato [7 ]
Ogura, Masakazu [8 ]
Itasaka, Satoshi [9 ]
Yamauchi, Chikako [10 ]
Otsu, Shuji [11 ]
Sakamoto, Takashi [12 ]
Sakamoto, Masato [5 ]
Araki, Norio [13 ]
Hirashima, Hideaki [2 ,3 ]
Adachi, Takanori [1 ,2 ]
Matsuo, Yukinori [2 ]
Mizowaki, Takashi [2 ]
机构
[1] Kyoto Univ, Div Med Phys, Dept Informat Technol & Med Engn, Human Hlth Sci,Grad Sch Med,Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan
[2] Kyoto Univ Hosp, Dept Radiat Oncol & Image Appl Therapy, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan
[3] Japan Soc Promot Sci, Chiyoda Ku, 5-3-1 Kojimachi, Tokyo 1020083, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Radiat Oncol, Chuo Ku, 2-1-1 Minatojimaminamimachi, Kobe, Hyogo 6500047, Japan
[5] Japanese Red Cross Fukui Hosp, Dept Radiol, 2-4-1 Tsukimi, Fukui 9188501, Japan
[6] Tenri Hosp, Dept Radiol, 200 Mishima Cho, Tenri, Nara 6328552, Japan
[7] Nagahama City Hosp, Dept Radiat Oncol, 313 Oinui Cho, Nagahama, Shiga 5260043, Japan
[8] Kishiwada City Hosp, Dept Radiat Oncol, 1001 Gakuhara Cho, Kishiwada, Osaka 5968501, Japan
[9] Kurashiki Cent Hosp, Dept Radiat Oncol, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan
[10] Shiga Gen Hosp, Dept Radiat Oncol, 5-4-30 Moriyama, Moriyama, Shiga 5248524, Japan
[11] Kyoto City Hosp, Dept Radiat Oncol, Nakagyo Ku, 1-2 Mibuhigashitakada Cho, Kyoto 6048845, Japan
[12] Kyoto Katsura Hosp, Dept Radiat Oncol, Nishikyo Ku, 17 Yamadahirao Cho, Kyoto 6158256, Japan
[13] Natl Hosp Org Kyoto Med Ctr, Dept Radiat Oncol, Fushimi Ku, 1-1 Fukakusamukaihata Cho, Kyoto 6128555, Japan
基金
日本学术振兴会;
关键词
distant metastasis; NSCLC; radiomics; random survival forest; SBRT; RADIATION-THERAPY; STAGE-I; ABLATIVE RADIOTHERAPY; CANCER; FEATURES; PHASE; TRIAL;
D O I
10.1002/mp.14380
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To predict local recurrence (LR) and distant metastasis (DM) in early stage non-small cell lung cancer (NSCLC) patients after stereotactic body radiotherapy (SBRT) in multiple institutions using breath-hold computed tomography (CT)-based radiomic features with random survival forest. Methods A total of 573 primary early stage NSCLC patients who underwent SBRT between January 2006 and March 2016 and met the eligibility criteria were included in this study. Patients were divided into two datasets: training (464 patients in 10 institutions) and test (109 patients in one institution) datasets. A total of 944 radiomic features were extracted from manually segmented gross tumor volumes (GTVs). Feature selection was performed by analyzing inter-segmentation reproducibility, GTV correlation, and inter-feature redundancy. Nine clinical factors, including histology and GTV size, were also used. Three prognostic models (clinical, radiomic, and combined) for LR and DM were constructed using random survival forest (RSF) to deal with total death as a competing risk in the training dataset. Robust models with optimal hyper-parameters were determined using fivefold cross-validation. The patients were dichotomized into two groups based on the median value of the patient-specific risk scores (high- and low-risk score groups). Gray's test was used to evaluate the statistical significance between the two risk score groups. The prognostic power was evaluated by the concordance index with the 95% confidence intervals (CI) via bootstrapping (2000 iterations). Results The concordance indices at 3 yr of clinical, radiomic, and combined models for LR were 0.57 [CI: 0.39-0.75], 0.55 [CI: 0.38-0.73], and 0.61 [CI: 0.43-0.78], respectively, whereas those for DM were 0.59 [CI: 0.54-0.79], 0.67 [CI: 0.54-0.79], and 0.68 [CI: 0.55-0.81], respectively, in the test dataset. The combined DM model significantly discriminated its cumulative incidence between high- and low-risk score groups (P < 0.05). The variable importance of RSF in the combined model for DM indicated that two radiomic features were more important than other clinical factors. The feature maps generated on the basis of the most important radiomic feature had visual difference between high- and low-risk score groups. Conclusions The radiomics approach with RSF for competing risks using breath-hold CT-based radiomic features might predict DM in early stage NSCLC patients who underwent SBRT although that may not have potential to predict LR.
引用
收藏
页码:4634 / 4643
页数:10
相关论文
共 43 条
  • [1] Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC
    Ackerson, Bradley G.
    Tong, Betty C.
    Hong, Julian C.
    Gu, Lin
    Chino, Junzo
    Trotter, Jacob W.
    D'Amico, Thomas A.
    Torok, Jordan A.
    Lafata, Kyle
    Chang, Catherine
    Kelsey, Chris R.
    [J]. LUNG CANCER, 2018, 125 : 185 - 191
  • [2] Beyond imaging: The promise of radiomics
    Avanzo, Michele
    Stancanello, Joseph
    El Naqa, Issam
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2017, 38 : 122 - 139
  • [3] Prediction of early mortality following stereotactic body radiotherapy for peripheral early-stage lung cancer
    Baker, Sarah
    Sharma, Aman
    Peric, Robert
    Heemsbergen, Wilma D.
    Nuyttens, Joost Jan
    [J]. ACTA ONCOLOGICA, 2019, 58 (02) : 237 - 242
  • [4] Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
    Baumann, Pia
    Nyman, Jan
    Hoyer, Morten
    Wennberg, Berit
    Gagliardi, Giovanna
    Lax, Ingmar
    Drugge, Ninni
    Ekberg, Lars
    Friesland, Signe
    Johansson, Karl-Axel
    Lund, Jo-Asmund
    Morhed, Elisabeth
    Nilsson, Kristina
    Levin, Nina
    Paludan, Merete
    Sederholm, Christer
    Traberg, Anders
    Wittgren, Lena
    Lewensohn, Rolf
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3290 - 3296
  • [5] Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
    Bernstein, Michael B.
    Krishnan, Sunil
    Hodge, James W.
    Chang, Joe Y.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (08) : 516 - 524
  • [6] Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy
    Cerra-Franco, Alberto
    Liu, Sheng
    Azar, Michella
    Shiue, Kevin
    Freije, Samantha
    Hinton, Ason
    Deig, Christopher R.
    Edwards, Donna
    Estabrook, Neil C., III
    Ellsworth, Susannah G.
    Huang, Ke
    Diab, Khalil
    Langer, Mark P.
    Zellars, Richard
    Kong, Feng-Ming
    Wan, Jun
    Lautenschlaeger, Tim
    [J]. CLINICAL LUNG CANCER, 2019, 20 (03) : 186 - +
  • [7] Random forests for genomic data analysis
    Chen, Xi
    Ishwaran, Hemant
    [J]. GENOMICS, 2012, 99 (06) : 323 - 329
  • [8] CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
    Coroller, Thibaud P.
    Grossmann, Patrick
    Hou, Ying
    Velazquez, Emmanuel Rios
    Leijenaar, Ralph T. H.
    Hermann, Gretchen
    Lambin, Philippe
    Haibe-Kains, Benjamin
    Mak, Raymond H.
    Aerts, Hugo J. W. L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 114 (03) : 345 - 350
  • [9] Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer
    Dreyer, Julia
    Bremer, Michael
    Henkenberens, Christoph
    [J]. RADIATION ONCOLOGY, 2018, 13
  • [10] HATT M, 2018, J NUCL MED S1, V59